Good news on the gene therapy front

Good news on the gene therapy front: very encouraging results from a phase III clinical trial of nadofaragene firadenovec, a recombinant adenovirus-expressing interferon alfa for treatment of bladder cancer unresponssive to conventional BCG therapy.